Clinical Everolimus Experience in Pediatric Renal Transplant Patients
Makaleler > Tam Makale · 2013
Yazarlar: N. DINCEL, İpek KAPLAN BULUT, Taylan Özgür SEZER, S. MIR, C. HOSCOSKUN
TRANSPLANTATION PROCEEDINGS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2013, cilt 45, ss 913-916
DOI: 10.1016/j.transproceed.2013.02.076
Özet
Objective. Everolimus is a potent immunosuppressive agent that has antiproliferative activities. This study sought to share our experience among renal transplanted children who required conversion from calcineurin inhibitors (CNIs) to the mammalian target of rapamycin inhibitor everolimus.